Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial-Reference-Cited by-同舟云学术

Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial

Published:2020-04 Issue:4 Volume:5 Page:317-327
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Garcia-Lunar Ines,Blanco Isabel,Fernández-Friera Leticia,Prat-Gonzàlez Susanna,Jordà Paloma,Sánchez Javier,Pereda Daniel,Pujadas Sandra,Rivas-Lasarte Mercedes,Solé-Gonzalez Eduard,Vázquez Jorge,Blázquez Zorba,García-Picart Juan,Caravaca Pedro,Escalera Noemí,Garcia-Pavia Pablo,Delgado Juan,Segovia-Cubero Javier,Fuster Valentín,Roig Eulalia,Barberá Joan Albert,Ibanez Borja,García-Álvarez Ana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure;Ghio;J Am Coll Cardiol,2001

2. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study;Lam;J Am Coll Cardiol,2009

3. Pulmonary hypertension due to left heart disease;Guazzi;Circulation,2012

4. Pulmonary pressures and death in heart failure: a community study;Bursi;J Am Coll Cardiol,2012

5. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure;Grigioni;J Heart Lung Transplant,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiological and metabolic functions of the β3-adrenergic receptor and an approach to therapeutic achievements;Journal of Physiology and Biochemistry;2024-08-15

2. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury;Basic Research in Cardiology;2024-08-12

3. The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets;Vascular Pharmacology;2023-08

4. Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease;PLOS ONE;2023-05-22

5. β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure ( SPHERE‐HF ): a double blind, placebo‐controlled, randomized clinical trial;European Journal of Heart Failure;2022-12-04